Search results
Wall Street Analysts Think Catalyst (CPRX) Could Surge 26.44%: Read This Before Placing a Bet
Zacks via Yahoo Finance· 1 year agoThe average of price targets set by Wall Street analysts indicates a potential upside of 26.4% in...
Catalyst (CPRX) Q4 Earnings & Sales Beat Estimates, Stock Up
Zacks via Yahoo Finance· 2 months agoCatalyst Pharmaceuticals, Inc. CPRX reported adjusted diluted earnings of 53 cents per share for the...
Is Trending Stock Catalyst Pharmaceuticals, Inc. (CPRX) a Buy Now?
Zacks via Yahoo Finance· 1 year agoCatalyst Pharmaceutical (CPRX) has recently been on Zacks.com's list of the most searched stocks....
Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) high institutional ownership speaks for itself as...
Simply Wall St. via Yahoo Finance· 12 months agoKey Insights Institutions' substantial holdings in Catalyst Pharmaceuticals implies that they have...
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is largely controlled by institutional shareholders who...
Simply Wall St. via Yahoo Finance· 3 weeks agoKey Insights Given the large stake in the stock by institutions, Catalyst Pharmaceuticals' stock...
Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Stock Is Going Strong: Is the Market Following...
Simply Wall St. via Yahoo Finance· 2 years agoCatalyst Pharmaceuticals (NASDAQ:CPRX) has had a great run on the share market with its stock up by...
Is Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Recent Stock Performance Tethered To Its Strong...
Simply Wall St. via Yahoo Finance· 4 months agoCatalyst Pharmaceuticals (NASDAQ:CPRX) has had a great run on the share market with its stock up by...
Here's Why Catalyst Pharmaceutical (CPRX) is a Great Momentum Stock to Buy
Zacks via Yahoo Finance· 2 years agoMomentum investing is all about the idea of following a stock's recent trend, which can be in either...
Institutional owners may take dramatic actions as Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX)...
Simply Wall St. via Yahoo Finance· 6 months agoKey Insights Significantly high institutional ownership implies Catalyst Pharmaceuticals' stock...
Are Investors Undervaluing Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) By 50%?
Simply Wall St. via Yahoo Finance· 1 year agoHow far off is Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) from its intrinsic value? Using the most...